Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Occup Environ Med ; 60(12): 1108-1111, 2018 12.
Artigo em Inglês | MEDLINE | ID: mdl-30252722

RESUMO

OBJECTIVE: The association of American Medical Association's (AMA) Guides edition with impairment ratings is uncertain. METHODS: We used data from a consecutive sample of 249 injured workers referred for an independent evaluation 10 months before and after assessors switched from the 5th to the 6th edition of the AMA Guides. RESULTS: The median whole person impairment rating was 7.0% (interquartile range [IQR]: 4 to 14) for 131 claimants assessed with the 5th edition of the Guides, and 4.0% (IQR: 2 to 8) for 118 claimants assessed with the 6th edition (P-value for difference: 0.002). Multivariable analysis showed a 36.4% relative reduction (95% confidence interval [CI] 17.2% to 57.3%) in impairment rating with the 6th edition of the Guides versus the 5th edition. CONCLUSIONS: The 6th edition of the AMA Guides provides systematically lower impairment ratings for injured workers than the 5th edition.


Assuntos
Guias como Assunto , Traumatismos Ocupacionais/complicações , Avaliação da Capacidade de Trabalho , Indenização aos Trabalhadores/normas , Adolescente , Adulto , Idoso , Canadá , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Países Baixos , Estados Unidos , Adulto Jovem
2.
BMJ Open ; 6(11): e011957, 2016 11 24.
Artigo em Inglês | MEDLINE | ID: mdl-27884842

RESUMO

INTRODUCTION: Tuberculosis (TB) continues to be a major public health issue worldwide, with 1.4 million deaths occurring annually. There is uncertainty regarding which factors are associated with in-hospital mortality among patients with pulmonary TB. This knowledge gap complicates efforts to identify and improve the management of those individuals with TB at greatest risk of death. The aim of this systematic review and meta-analysis is to establish predictors of in-hospital mortality among patients with pulmonary TB to enhance the evidence base for public policy. METHODS AND ANALYSIS: Studies will be identified by a MEDLINE, EMBASE and Global Health search. Eligible studies will be cohort and case-control studies that report predictors or risk factors for in-hospital mortality among patients with pulmonary TB and an adjusted analysis to explore factors associated with in-hospital mortality. We will use the Grading of Recommendations Assessment, Development and Evaluation approach to summarise the findings of some reported predictors. Teams of 2 reviewers will screen the titles and abstracts of all citations identified in our search, independently and in duplicate, extract data, and assess scientific quality using standardised forms quality assessment and tools tailored. We will pool all factors that were assessed for an association with mortality that were reported by >1 study, and presented the OR and the associated 95% CI. When studies provided the measure of association as a relative risk (RR), we will convert the RR to OR using the formula provided by Wang. For binary data, we will calculate a pooled OR, with an associated 95% CI. ETHICS AND DISSEMINATION: This study is based on published data, and therefore ethical approval is not a requirement. Findings will be disseminated through publication in peer-reviewed journals and conference presentations at relevant conferences. TRIAL REGISTRATION NUMBER: CRD42015025755.


Assuntos
Mortalidade Hospitalar , Tuberculose Pulmonar/mortalidade , Humanos , Estudos Observacionais como Assunto , Projetos de Pesquisa , Fatores de Risco , Revisões Sistemáticas como Assunto
3.
BMJ Open ; 4(11): e006112, 2014 Nov 20.
Artigo em Inglês | MEDLINE | ID: mdl-25412864

RESUMO

INTRODUCTION: Chronic neuropathic pain is associated with reduced health-related quality of life and substantial socioeconomic costs. Current research addressing management of chronic neuropathic pain is limited. No review has evaluated all interventional studies for chronic neuropathic pain, which limits attempts to make inferences regarding the relative effectiveness of treatments. METHODS AND ANALYSIS: We will conduct a systematic review of all randomised controlled trials evaluating therapies for chronic neuropathic pain. We will identify eligible trials, in any language, by a systematic search of CINAHL, EMBASE, MEDLINE, AMED, HealthSTAR, DARE, PsychINFO and the Cochrane Central Registry of Controlled Trials. Eligible trials will be: (1) enrol patients presenting with chronic neuropathic pain, and (2) randomise patients to alternative interventions (pharmacological or non-pharmacological) or an intervention and a control arm. Pairs of reviewers will, independently and in duplicate, screen titles and abstracts of identified citations, review the full texts of potentially eligible trials and extract information from eligible trials. We will use a modified Cochrane instrument to evaluate risk of bias of eligible studies, recommendations from the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) to inform the outcomes we will collect, and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system to evaluate our confidence in treatment effects. When possible, we will conduct: (1) in direct comparisons, a random-effects meta-analysis to establish the effect of reported therapies on patient-important outcomes; and (2) a multiple treatment comparison meta-analysis within a Bayesian framework to assess the relative effects of treatments. We will define a priori hypotheses to explain heterogeneity between studies, and conduct meta-regression and subgroup analyses consistent with the current best practices. ETHICS AND DISSEMINATION: We do not require ethics approval for our proposed review. We will disseminate our findings through peer-reviewed publications and conference presentations. TRIAL REGISTRATION NUMBER: PROSPERO (CRD42014009212).


Assuntos
Dor Crônica/terapia , Neuralgia/terapia , Manejo da Dor , Humanos , Ensaios Clínicos Controlados Aleatórios como Assunto , Projetos de Pesquisa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...